Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vijayachandra, K.
Right arrow Articles by Glick, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vijayachandra, K.
Right arrow Articles by Glick, A. B.
[Cancer Research 63, 3447-3452, July 1, 2003]
© 2003 American Association for Cancer Research


Advances in Brief

Smad3 Regulates Senescence and Malignant Conversion in a Mouse Multistage Skin Carcinogenesis Model

Kinnimulki Vijayachandra, Jessica Lee and Adam B. Glick1

Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, Maryland 20892

Transforming growth factor ß (TGF-ß) is a growth-inhibitory cytokine for epithelial cells. In the mouse multistage skin carcinogenesis model, defects in TGF-ß1 signaling reduce senescence in vitro and accelerate malignant progression in vivo. However, the precise postreceptor signaling pathways and specific roles played by Smad proteins in this process have not been defined. Here we show that senescence of v-rasHa-transduced Smad3 null keratinocytes is delayed, whereas overexpression of Smad3, but not Smad2 or Smad4, induced senescence. The TGF-ß1 target genes c-myc and p15ink4b were deregulated in the absence of Smad3. When transplanted to a graft site on nude mice, the v-rasHa-transduced Smad3 null keratinocytes underwent rapid conversion from benign papilloma to malignant carcinoma, whereas wild-type keratinocytes predominantly formed papillomas. These results link Smad3-mediated regulation of growth control genes to senescence in vitro and tumor suppression in vivo.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
A. Shukla, Y. Ho, X. Liu, A. Ryscavage, and A. B. Glick
Cripto-1 Alters Keratinocyte Differentiation via Blockade of Transforming Growth Factor-{beta}1 Signaling: Role in Skin Carcinogenesis
Mol. Cancer Res., March 1, 2008; 6(3): 509 - 516.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. A. Stepp, Y. Liu, S. Pal-Ghosh, R. A. Jurjus, G. Tadvalkar, A. Sekaran, K. LoSicco, L. Jiang, M. Larsen, L. Li, et al.
Reduced migration, altered matrix and enhanced TGFbeta1 signaling are signatures of mouse keratinocytes lacking Sdc1
J. Cell Sci., August 15, 2007; 120(16): 2851 - 2863.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Wei, S. Ku, G. K. Ma, S. Saito, A. A. Tang, J. Zhang, J.-H. Mao, E. Appella, A. Balmain, and E. J. Huang
HIPK2 represses beta-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis
PNAS, August 7, 2007; 104(32): 13040 - 13045.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
K. S. Suh, M. Mutoh, T. Mutoh, L. Li, A. Ryscavage, J. M. Crutchley, R. A. Dumont, C. Cheng, and S. H. Yuspa
CLIC4 mediates and is required for Ca2+-induced keratinocyte differentiation
J. Cell Sci., August 1, 2007; 120(15): 2631 - 2640.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Li, D. Xu, J. Li, M. C. Berndt, and J.-P. Liu
Transforming Growth Factor beta Suppresses Human Telomerase Reverse Transcriptase (hTERT) by Smad3 Interactions with c-Myc and the hTERT Gene
J. Biol. Chem., September 1, 2006; 281(35): 25588 - 25600.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. Ju, A. Ogawa, J. Heyer, D. Nierhof, L. Yu, R. Kucherlapati, D. A. Shafritz, and E. P. Bottinger
Deletion of Smad2 in Mouse Liver Reveals Novel Functions in Hepatocyte Growth and Differentiation
Mol. Cell. Biol., January 15, 2006; 26(2): 654 - 667.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. G. Li, S.-L. Lu, M.-X. Zhang, C. Deng, and X.-J. Wang
Smad3 Knockout Mice Exhibit a Resistance to Skin Chemical Carcinogenesis
Cancer Res., November 1, 2004; 64(21): 7836 - 7845.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Liu, J. Lee, M. Cooley, E. Bhogte, S. Hartley, and A. Glick
Smad7 but not Smad6 Cooperates with Oncogenic ras to Cause Malignant Conversion in a Mouse Model for Squamous Cell Carcinoma
Cancer Res., November 15, 2003; 63(22): 7760 - 7768.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.